Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Thrombosis Research
|
October 1, 1978
Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors
E Amundsen, M J Gallimore, A O Aasen, et al.
The EMBO Journal
|
August 1, 1989
Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation
R J Grand, P W Grabham, M J Gallimore, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1989
Changes in the kallikrein-kinin-system after different dose regimen of aprotinin during cardiopulmonary bypass operation
W Heller, G Fuhrer, M J Gallimore, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1986
Levels of IgA, IgM, IgG and complement components during extracorporal circulation
W Heller, G Fuhrer, M J Gallimore, et al.
Thrombosis and Haemostasis
|
March 28, 2002
Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome
D W Jone, P J Nicholls, S Donohoe, et al.
Thrombosis Research
|
February 1, 1978
Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs
M J Gallimore, A O Aasen, K H Lyngaas, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome
S L Harris, D W Jones, M J Gallimore, et al.
Thrombosis Research
|
January 1, 1979
Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate
M J Gallimore, E Amundsen, A O Aasen, et al.
Thrombosis and Haemostasis
|
January 11, 1993
Contact activation, heparins and cardiopulmonary bypass
M J Gallimore, W Heller, G Fuhrer, et al.
Thrombosis and Haemostasis
|
July 6, 1992
Contact activation, heparins and cardiopulmonary bypass
M J Gallimore, W Heller, G Fuhrer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Thrombosis Research
|
October 1, 1978
Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors
E Amundsen, M J Gallimore, A O Aasen, et al.
The EMBO Journal
|
August 1, 1989
Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation
R J Grand, P W Grabham, M J Gallimore, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1989
Changes in the kallikrein-kinin-system after different dose regimen of aprotinin during cardiopulmonary bypass operation
W Heller, G Fuhrer, M J Gallimore, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1986
Levels of IgA, IgM, IgG and complement components during extracorporal circulation
W Heller, G Fuhrer, M J Gallimore, et al.
Thrombosis and Haemostasis
|
March 28, 2002
Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome
D W Jone, P J Nicholls, S Donohoe, et al.
Thrombosis Research
|
February 1, 1978
Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs
M J Gallimore, A O Aasen, K H Lyngaas, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome
S L Harris, D W Jones, M J Gallimore, et al.
Thrombosis Research
|
January 1, 1979
Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate
M J Gallimore, E Amundsen, A O Aasen, et al.
Thrombosis and Haemostasis
|
January 11, 1993
Contact activation, heparins and cardiopulmonary bypass
M J Gallimore, W Heller, G Fuhrer, et al.
Thrombosis and Haemostasis
|
July 6, 1992
Contact activation, heparins and cardiopulmonary bypass
M J Gallimore, W Heller, G Fuhrer, et al.
Page
of 7